MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Educational Programs for Patients with Parkinson disease and Deep Brain Stimulation: Scoping Riview

    M. Petralito, C. Tedesco, F. Fanari, G. Pucciarelli, R. Caruso (Roma, Italy)

    Objective: Map the literature on educational programs for patients with Parkinson's disease and Deep Brain Stimulation, analysing the characteristics that the programmes have and the…
  • 2024 International Congress

    A Post-mortem Study on Striatal Glia and Blood Brain Barrier Integrity in Aging and PD Asian-Indians.

    H J. Jyothi, A. Mahadevan, U. Muthane, T C. Yasha, P. Alladi (Bengaluru, India)

    Objective: We examined the glial and blood brain barrier (BBB) changes related to normal aging and PD in the Asian-Indian striatum. Background: increases the risk…
  • 2024 International Congress

    Late-onset neurologic Wilson’s disease: case series

    I. Minaev, E. Nuzhnyi, V. Poleschuk, A. Protopopova, N. Abramycheva, S. Illarioshkin (Moscow, Russian Federation)

    Objective: To report the case series of patients with late-onset Wilson’s disease (WD) with predominantly neurological manifestation. Background: WD is a rare and treatable disorder…
  • 2024 International Congress

    Idiopathic Parkinson’s disease and Normal pressure Hydrocephalus – a tale of two sisters

    P. Vvsrk, S. Kola, R. Alugolu, R. Kandadani, R. Borgohain (Hyderabad, India)

    Objective: Idiopathic Parkinson's disease (PD) and Normal pressure hydrocephalus (NPH) can have similar clinical presentation. However, diagnostic precision is important as clinical management differs. Previous…
  • 2024 International Congress

    PD Young Ambassadors: A Peer-led, Community-Based Intervention to Raise PD Awareness in the Hispanic Communities of Chicago.

    J. Deliz, E. Espinoza, S. Kola, E. Zivin, K. Williams, J. Adrissi, P. Gonzalez-Latapi, D. Larson (Chicago, USA)

    Objective: To employ a community-based participatory research (CBPR) approach in developing and testing a workshop-based, peer-led intervention aimed at increasing PD awareness among youth and…
  • 2024 International Congress

    Syllable-based speech characteristics as potential biomarker for differential diagnosis of Parkinson’s disease, multiple system atrophy, and cerebellar ataxia

    B. Jin, H. Kim, K. Woo, J. Shin (Seoul, Republic of Korea)

    Objective: To analyze syllable-based speech characteristics in patients with Parkinson’s disease (PD), multiple system atrophy (MSA), and cerebellar ataxia (CA) to determine if there is…
  • 2024 International Congress

    Correlation of lmaging Markers with Clinical Features in Multiple System Atrophy Patients

    N. Jin (Hangzhou, China)

    Objective: This study aims to investigate the correlation between visually assessable imaging markers and their clinical symptoms in Multiple System Atrophy (MSA) patients. Background: MSA is…
  • 2024 International Congress

    Tau Deposition in Locus Coeruleus is Associated with Rapid Eye Movement Sleep Behavior Disorder in Progressive Supranuclear Palsy.

    X. Li, FT. Liu (Shanghai, China)

    Objective: In this study, we aimed to investigate the frequency of Rapid eye movement sleep behavior disorder (RBD) occurring in a large cohort of PSP,…
  • 2024 International Congress

    Peripheral inflammation severity in differential diagnosis of progressive supranuclear palsy and multiple system atrophy – usefulness of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and neutrophil-to-high-density lipoprotein-cholesterol ratio

    N. Madetko-Alster, B. Migda, P. Chunowski, P. Alster (Warsaw, Poland)

    Objective: Assessment of the possible differences in peripheral inflammation severity between progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) with the use of three…
  • 2024 International Congress

    PSP: a Clinical Case

    K. Manysheva, D. Makhmudova (Makhachkala, Russian Federation)

    Objective: PSP is traditionally considered a neurodegenerative disease of late life. Its diagnostic criteria include the item “age of onset over 40 years.” This significantly…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley